S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
Log in
NYSE:TFX

Teleflex Stock Forecast, Price & News

$386.44
-2.28 (-0.59 %)
(As of 01/22/2021 12:00 AM ET)
Add
Compare
Today's Range
$384.66
Now: $386.44
$388.55
50-Day Range
$380.67
MA: $397.72
$413.38
52-Week Range
$221.27
Now: $386.44
$414.72
Volume197,766 shs
Average Volume232,283 shs
Market Capitalization$18.00 billion
P/E Ratio49.73
Dividend Yield0.35%
Beta1.14
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters and related devices, including catheter positioning systems for use in the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products consist of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology product comprises the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings. It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management for patients in the hospital and individuals in the home care markets. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. The company was founded in 1943 and is headquartered in Wayne, Pennsylvania.
Teleflex logo

MarketRank

Overall MarketRank

1.98 out of 5 stars

Medical Sector

60th out of 1,925 stocks

Surgical & Medical Instruments Industry

9th out of 169 stocks

Analyst Opinion: 2.5Community Rank: 2.2Dividend Strength: 1.7Insider Behavior: 1.7Valuation: 1.9 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
CUSIP87936910
Phone610-225-6800
Employees14,400

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.60 billion
Cash Flow$15.60 per share
Book Value$64.35 per share

Profitability

Net Income$461.47 million

Miscellaneous

Market Cap$18.00 billion
Next Earnings Date2/18/2021 (Estimated)
OptionableOptionable
$386.44
-2.28 (-0.59 %)
(As of 01/22/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive TFX News and Ratings via Email

Sign-up to receive the latest news and ratings for TFX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Teleflex (NYSE:TFX) Frequently Asked Questions

How has Teleflex's stock price been impacted by COVID-19 (Coronavirus)?

Teleflex's stock was trading at $342.08 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, TFX stock has increased by 13.0% and is now trading at $386.44.
View which stocks have been most impacted by COVID-19
.

Is Teleflex a buy right now?

11 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Teleflex in the last year. There are currently 1 hold rating, 9 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Teleflex stock.
View analyst ratings for Teleflex
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Teleflex?

Wall Street analysts have given Teleflex a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Teleflex wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

What is Larry J. Merlo's approval rating as Teleflex's CEO?

6,978 employees have rated Teleflex CEO Larry J. Merlo on Glassdoor.com. Larry J. Merlo has an approval rating of 37% among Teleflex's employees. This puts Larry J. Merlo in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

When is Teleflex's next earnings date?

Teleflex is scheduled to release its next quarterly earnings announcement on Thursday, February 18th 2021.
View our earnings forecast for Teleflex
.

How were Teleflex's earnings last quarter?

Teleflex Incorporated (NYSE:TFX) posted its quarterly earnings data on Thursday, October, 29th. The medical technology company reported $2.77 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.24 by $0.53. The medical technology company earned $628.30 million during the quarter, compared to the consensus estimate of $618.18 million. Teleflex had a return on equity of 16.33% and a net margin of 14.66%. The business's revenue was down 3.1% compared to the same quarter last year. During the same period in the prior year, the firm posted $2.97 EPS.
View Teleflex's earnings history
.

How often does Teleflex pay dividends? What is the dividend yield for Teleflex?

Teleflex announced a quarterly dividend on Thursday, October 29th. Stockholders of record on Sunday, November 15th will be given a dividend of $0.34 per share on Tuesday, December 15th. This represents a $1.36 dividend on an annualized basis and a yield of 0.35%. The ex-dividend date is Thursday, November 12th.
View Teleflex's dividend history
.

Is Teleflex a good dividend stock?

Teleflex pays an annual dividend of $1.36 per share and currently has a dividend yield of 0.35%. The dividend payout ratio of Teleflex is 12.20%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Teleflex will have a dividend payout ratio of 10.78% next year. This indicates that Teleflex will be able to sustain or increase its dividend.
View Teleflex's dividend history.

What price target have analysts set for TFX?

11 brokerages have issued 12-month target prices for Teleflex's stock. Their forecasts range from $275.00 to $455.00. On average, they expect Teleflex's stock price to reach $416.27 in the next twelve months. This suggests a possible upside of 7.7% from the stock's current price.
View analysts' price targets for Teleflex
or view Wall Street analyst' top-rated stocks.

Who are some of Teleflex's key competitors?

What other stocks do shareholders of Teleflex own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Teleflex investors own include NVIDIA (NVDA), AbbVie (ABBV), Johnson & Johnson (JNJ), Alibaba Group (BABA), Lam Research (LRCX), ServiceNow (NOW), QUALCOMM (QCOM), Advanced Micro Devices (AMD), salesforce.com (CRM) and Cisco Systems (CSCO).

Who are Teleflex's key executives?

Teleflex's management team includes the following people:
  • Mr. Liam J. Kelly, Chairman, Pres & CEO (Age 54, Pay $2.33M)
  • Mr. Thomas E. Powell, Exec. VP & CFO (Age 59, Pay $1.2M)
  • Mr. James J. Leyden, Corp. VP, Gen. Counsel & Sec. (Age 54, Pay $591.92k)
  • Mr. Cameron P. Hicks, Corp. VP of HR & Communications (Age 56, Pay $557.86k)
  • Mr. John R. Deren, VP & Chief Accounting Officer
  • Mr. Timothy F. Duffy, VP & Chief Information Officer
  • Mr. Jacob P. Elguicze, Treasurer & VP of Investor Relations (Age 48)
  • Ms. Gwen Chapman, Chief Compliance Officer & Corp. VP (Age 46)
  • Ms. Gwendolyn Ann Watanabe, Corp. VP of Global Corp. Devel., Strategy and Strategic Partnerships (Age 50)
  • Mr. David R. Amerson, Pres & GM of Interventional Urology

What is Teleflex's stock symbol?

Teleflex trades on the New York Stock Exchange (NYSE) under the ticker symbol "TFX."

Who are Teleflex's major shareholders?

Teleflex's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Frontier Capital Management Co. LLC (0.38%), AMI Asset Management Corp (0.25%), Mountain Pacific Investment Advisers Inc. ID (0.16%), Sarasin & Partners LLP (0.13%), Scout Investments Inc. (0.10%) and Gateway Investment Advisers LLC (0.07%). Company insiders that own Teleflex stock include Benson Smith, Cameron P Hicks, James J Leyden, John C Heinmiller, John Deren, Karen Boylan, Stephen K MD Klasko, Stuart A Randle and Thomas E Powell.
View institutional ownership trends for Teleflex
.

Which major investors are selling Teleflex stock?

TFX stock was sold by a variety of institutional investors in the last quarter, including Frontier Capital Management Co. LLC, Tributary Capital Management LLC, Pacer Advisors Inc., AMI Asset Management Corp, State of Alaska Department of Revenue, Scout Investments Inc., Donaldson Capital Management LLC, and Crossmark Global Holdings Inc.. Company insiders that have sold Teleflex company stock in the last year include Cameron P Hicks, James J Leyden, John Deren, and Stephen K MD Klasko.
View insider buying and selling activity for Teleflex
or view top insider-selling stocks.

Which major investors are buying Teleflex stock?

TFX stock was purchased by a variety of institutional investors in the last quarter, including Sarasin & Partners LLP, IFM Investors Pty Ltd, Wambolt & Associates LLC, Louisiana State Employees Retirement System, Newfound Research LLC, Candriam Luxembourg S.C.A., Raymond James Trust N.A., and BLB&B Advisors LLC.
View insider buying and selling activity for Teleflex
or or view top insider-buying stocks.

How do I buy shares of Teleflex?

Shares of TFX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Teleflex's stock price today?

One share of TFX stock can currently be purchased for approximately $386.44.

How big of a company is Teleflex?

Teleflex has a market capitalization of $18.00 billion and generates $2.60 billion in revenue each year. The medical technology company earns $461.47 million in net income (profit) each year or $11.15 on an earnings per share basis. Teleflex employs 14,400 workers across the globe.

What is Teleflex's official website?

The official website for Teleflex is www.teleflex.com.

How can I contact Teleflex?

Teleflex's mailing address is 550 E SWEDESFORD RD, WAYNE PA, 19087. The medical technology company can be reached via phone at 610-225-6800 or via email at [email protected]

This page was last updated on 1/23/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.